Featured Archives - Milford Asset
Investing in changing times: Competition is now high on the President’s agenda

Alexander Whight, 03 Aug 2021

Competition and corporate consolidation. President Biden’s 2020 election campaign was relatively quiet when it came to this topic. We were…

Private investing provides better access to New Zealand’s growth sectors than the NZX 50

Brooke Bone, 29 Jul 2021

New Zealand’s listed stock market, at just 52% of New Zealand’s overall GDP in 2019, does not provide investors with…

Will higher oil prices see us all drive electric vehicles sooner?

Greg Cassidy, 29 Jul 2021

There are many areas in financial markets that are higher than before the onset of Covid-19. Despite a significant hit…

What is concerning the bond market?

Paul Morris, 20 Jul 2021

As economies repair from the pandemic, unemployment has fallen, and inflation has risen. As key objectives for central banks, this…

Sydney Airport acquisition ready for takeoff

Daniel Simmonds, 13 Jul 2021

Sydney Airport (SYD) has recently become an acquisition target by a consortium of private investors willing to take a longer-term…

Central bank policy in transition – are rate hikes on the way?

Travis Murdoch, 09 Jul 2021

As we enter the second half of the calendar year, central bank policies are entering the next phase of the…

Philanthropy – the benefits flow both ways

Richard Pilley, 05 Jul 2021

Who can be a philanthropist? You don’t need to be ultra-wealthy to be a philanthropist. The economic and environmental problems…

Isn’t the reopening trade over yet?

David Rigby, 30 Jun 2021

Compared to 18 months ago, we now know how to control COVID outbreaks by restricting movement and tracing contacts and…

The million dollar question: did Covid kill the office?

Jason Kururangi, 23 Jun 2021

If you take a walk around the streets of Sydney Tuesday to Thursday, you wouldn’t know we were still in…

COVID-19: creating a new era for vaccine and drug production

Dr Deborah Lambie, 22 Jun 2021

The COVID-19 pandemic has changed the global vaccine landscape, catapulting mRNA vaccines into the limelight for the first time, with…